News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,240 Results
Type
Article (14285)
Company Profile (281)
Press Release (254674)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79549)
Career Advice (153)
Deals (13234)
Drug Delivery (35)
Drug Development (50472)
Employer Resources (31)
FDA (5730)
Job Trends (5140)
News (144469)
Policy (10034)
Tag
Academia (916)
Accelerated approval (3)
Adcomms (13)
Allergies (52)
Alliances (21688)
ALS (69)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (110)
Approvals (5756)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (61)
Brain cancer (20)
Breast cancer (164)
Cancer (1543)
Cardiovascular disease (122)
Career advice (134)
Career pathing (2)
CAR-T (127)
Cell therapy (349)
Cervical cancer (9)
Clinical research (41203)
Collaboration (568)
Compensation (284)
Complete response letters (13)
COVID-19 (1034)
CRISPR (46)
C-suite (173)
Cystic fibrosis (78)
Data (1649)
Denatured (11)
Depression (32)
Diabetes (146)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (95)
Earnings (30260)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48864)
Executive appointments (478)
FDA (6514)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (522)
Gene editing (104)
Generative AI (10)
Gene therapy (273)
GLP-1 (375)
Government (1084)
Grass and pollen (2)
Guidances (75)
Healthcare (6596)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7282)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1387)
Liver cancer (34)
Lung cancer (212)
Lymphoma (107)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (65)
Medical device (2604)
Medtech (2605)
Mergers & acquisitions (6295)
Metabolic disorders (416)
Multiple sclerosis (55)
NASH (13)
Neurodegenerative disease (77)
Neuropsychiatric disorders (26)
Neuroscience (1289)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (23)
Obesity (201)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (126)
Partnered (8)
Patents (140)
Patient recruitment (84)
Peanut (35)
People (25696)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14562)
Phase II (19175)
Phase III (12102)
Pipeline (1000)
Policy (49)
Postmarket research (852)
Preclinical (6171)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (302)
Real estate (1419)
Recruiting (12)
Regulatory (8682)
Reports (17)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (7)
RSV (10)
Schizophrenia (64)
Series A (103)
Series B (70)
Service/supplier (1)
Sickle cell disease (43)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (218)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (145)
Last 7 days (623)
Last 30 days (2092)
Last 365 days (19359)
2025 (7417)
2024 (20551)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14350)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (44)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17360)
Australia (2948)
California (4174)
Canada (1192)
China (379)
Colorado (159)
Connecticut (157)
Delaware (110)
Europe (37388)
Florida (507)
Georgia (128)
Idaho (16)
Illinois (245)
India (10)
Indiana (94)
Iowa (3)
Japan (83)
Kansas (64)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (501)
Massachusetts (3313)
Michigan (75)
Minnesota (155)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1021)
New Mexico (12)
New York (1108)
North Carolina (578)
North Dakota (6)
Northern California (1869)
Ohio (118)
Oklahoma (9)
Oregon (21)
Pennsylvania (781)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1593)
Tennessee (26)
Texas (483)
United States (14188)
Utah (56)
Virginia (87)
Washington D.C. (31)
Washington State (369)
Wisconsin (19)
269,240 Results for "inhibikase therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inhibikase Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Activity
May 15, 2025
·
6 min read
Neurodegenerative disease
Inhibikase Scraps Parkinson’s Drug After Disappointing Mid-Stage Data
Inhibikase’s setback continues biopharma’s losing streak against Parkinson’s, marked by several clinical failures and abandoned assets in recent months.
January 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
April 14, 2025
·
3 min read
Press Releases
Inhibikase Therapeutics Announces 2024 Financial Results and Highlights Recent Activity
March 28, 2025
·
7 min read
Press Releases
Inhibikase Announces Expansion of Senior Leadership Team
February 25, 2025
·
6 min read
Genetown
Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs
Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.
June 5, 2024
·
6 min read
Press Releases
Inhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Activity
November 15, 2024
·
8 min read
Press Releases
Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth
February 19, 2025
·
7 min read
Business
Inhibikase Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity
Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases, reported financial results for the first quarter ended March 31, 2024 and highlighted recent developments.
May 15, 2024
·
9 min read
Drug Development
Inhibikase Therapeutics Completes Enrollment of the Phase 2 ‘201’ Trial Evaluating Risvodetinib in Untreated Parkinson’s DiseaseCompany expects to report trial results in 4Q24
Inhibikase Therapeutics, Inc. today announced the company has completed enrollment in the Phase 2 ‘201’ trial evaluating the safety and tolerability of risvodetinib (“risvo”).
June 17, 2024
·
4 min read
1 of 26,924
Next
